Panion & BF Biotech Inc Cash Flow Conversion Efficiency
Panion & BF Biotech Inc cash flow conversion efficiency. Based on the latest financial reports, Panion & BF Biotech Inc (1760) has a cash flow conversion efficiency ratio of 0.039x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$73.31 Million ≈ $2.31 Million USD) by net assets (NT$1.90 Billion ≈ $59.92 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Panion & BF Biotech Inc (2009–2024)
Cash flow conversion efficiency of Panion & BF Biotech Inc from 2009 to 2024. This chart illustrates how Panion & BF Biotech Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 1760 stock price for real-time trading data and today's change.
Panion & BF Biotech Inc Cash Flow Conversion Ratio Explained
Panion & BF Biotech Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Panion & BF Biotech Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Panion & BF Biotech Inc ranked by their cash flow conversion efficiency. Also see Panion & BF Biotech Inc (1760) market capitalisation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Fate Therapeutics Inc
NASDAQ:FATE
|
-0.104x |
|
Net Lease Office Properties
NYSE:NLOP
|
0.011x |
|
Yuen Chang Stainless Steel Co Ltd
TW:2069
|
-0.040x |
|
Diamond Building Products Public Company Limited
BK:DRT
|
0.054x |
|
Israel Land Development Urban Renewal Ltd
TA:ILDR
|
-0.151x |
|
Black Mammoth Metals Corp
V:BMM
|
-0.010x |
|
QRF SCA
BR:QRF
|
0.039x |
|
Greenland Resources Inc
NEO:MOLY
|
-0.139x |
Annual Cash Flow Conversion Efficiency for Panion & BF Biotech Inc (2009–2024)
The table below shows the annual cash flow conversion efficiency of Panion & BF Biotech Inc from 2009 to 2024. Review 1760 cash flow after capex ratio to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | NT$1.92 Billion ≈ $60.56 Million |
NT$351.19 Million ≈ $11.06 Million |
0.183x | +96.80% |
| 2023-12-31 | NT$1.91 Billion ≈ $60.21 Million |
NT$177.42 Million ≈ $5.59 Million |
0.093x | -61.96% |
| 2022-12-31 | NT$2.01 Billion ≈ $63.24 Million |
NT$489.87 Million ≈ $15.43 Million |
0.244x | +17.59% |
| 2021-12-31 | NT$1.93 Billion ≈ $60.90 Million |
NT$401.23 Million ≈ $12.64 Million |
0.208x | +1868.28% |
| 2020-12-31 | NT$1.24 Billion ≈ $39.07 Million |
NT$-14.55 Million ≈ $-458.56K |
-0.012x | -117.54% |
| 2019-12-31 | NT$1.36 Billion ≈ $42.83 Million |
NT$90.98 Million ≈ $2.87 Million |
0.067x | +15.01% |
| 2018-12-31 | NT$1.35 Billion ≈ $42.55 Million |
NT$78.58 Million ≈ $2.48 Million |
0.058x | -57.36% |
| 2017-12-31 | NT$835.25 Million ≈ $26.31 Million |
NT$113.97 Million ≈ $3.59 Million |
0.136x | -37.91% |
| 2016-12-31 | NT$806.41 Million ≈ $25.41 Million |
NT$177.22 Million ≈ $5.58 Million |
0.220x | +192.12% |
| 2015-12-31 | NT$775.03 Million ≈ $24.42 Million |
NT$58.30 Million ≈ $1.84 Million |
0.075x | -29.74% |
| 2014-12-31 | NT$710.84 Million ≈ $22.40 Million |
NT$76.11 Million ≈ $2.40 Million |
0.107x | -18.47% |
| 2013-12-31 | NT$656.55 Million ≈ $20.68 Million |
NT$86.22 Million ≈ $2.72 Million |
0.131x | +825.27% |
| 2012-12-31 | NT$278.86 Million ≈ $8.79 Million |
NT$3.96 Million ≈ $124.70K |
0.014x | +111.67% |
| 2011-12-31 | NT$296.98 Million ≈ $9.36 Million |
NT$-36.12 Million ≈ $-1.14 Million |
-0.122x | -164.01% |
| 2010-12-31 | NT$301.62 Million ≈ $9.50 Million |
NT$-13.89 Million ≈ $-437.77K |
-0.046x | -119.43% |
| 2009-12-31 | NT$324.61 Million ≈ $10.23 Million |
NT$76.98 Million ≈ $2.43 Million |
0.237x | -- |
About Panion & BF Biotech Inc
Panion & Bf Biotech Inc., a biotechnology pharmaceutical company, provides western medicines, cosmetics, testing reagents, food and chemical products in Taiwan, the United States, China, Hong Kong, Macau, and internationally. The company offers products in the areas of antibody, respiratory, gastrointestinal, COVID-19 IVD, antigen, anti-aging, active pharmaceutical ingredients, disease treatment,… Read more